MFX Appoints Dr. Katy Newton as Chief Scientific Officer to Drive Innovation for Cell-Based Therapies
MFX Appoints Dr. Katy Newton as Chief Scientific Officer to [...]
Ternary Therapeutics Arrives at SBC
We’re delighted to welcome Ternary Therapeutics to the SBC community! [...]
Mouthwash to treat side effects of cancer treatment (NG11-2) Phase-Ib clinical study results available
Mouthwash to treat side effects of cancer [...]
Monoclonal antibody delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps
Depemokimab delivers clinically meaningful and statistically significant [...]
Network established to identify opportunities for regulation to support innovation within advanced therapies
Network established to identify opportunities for regulation [...]
Samuel Atack Appointed as Operations Director at Stevenage Bioscience Catalyst
We’re delighted to announce that Samuel Atack [...]
Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience Innovation Forum in San Francisco
Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience [...]
LifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALS
LifeArc and Neuropeutics Inc join forces to [...]
New AI tool aims to detect early signs of dementia during routine eye tests
New AI tool aims to detect early [...]
Welcome INDICRO Ltd to Seed Works Shared Office!
It’s a pleasure to welcome new occupier [...]
